| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.03 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |